Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Lifotronic Technology Co., Ltd.

Lifotronic designs, develops, and manufactures medical devices, specializing in bedside treatment and diagnostic prod... read more Featured Products: More products

Download Mobile App





Lifotronic Demonstrates Latest Medical Innovations in Disease Diagnostics

By LabMedica International staff writers
Posted on 06 Feb 2024

Lifotronic (Shenzhen, China) is demonstrating its latest medical innovations, including its CLIA, HPLC, CBC, and POCT solutions, at Medlab Middle East 2024. More...

Lifotronic is presenting a comprehensive range of solutions for large, medium, and small-sized laboratories to a global audience of experts and scholars at the show. Lifotronic’s eCL8000, dubbed the king of emergency, is one of the featured technology products at the exhibition. eCL 8000 is an 86 T/H fully automated analyzer based on the most advanced Electro-chemiluminescence Immunoassay (ECLIA). More than 90 parameters are available, covering thyroid, fertility, tumor, cardiac, inflammation, bone metabolism markers, etc. At Medlab Middle East 2024, Lifotronic is introducing its latest product, the eCL9000 electro-chemiluminescence analyzer which is designed especially for large labs, hospitals, and chain labs. It can perform 300 tests per hour at a constant speed, meeting the high demand of more than 100 samples per day. It also allows end users to easily conduct immunoassay tests. With a super long walkaway time of 5.5 hours, it frees up the operator’s time, improves work efficiency, and creates a more relaxed and flexible work environment.

Lifotronic is also showcasing its latest H100 high-pressure liquid chromatography analyzer which has a test speed of 96s/T. Convenient, fast, and accurate, it also has a one-click switch function for HbA1c and thalassemia modes. H100 can greatly improve the analysis process and achieve the ideal balance of quality, efficiency, and cost. In addition, Lifotronic is highlighting the AC310 and AC610 hematology analyzers which are widely recognized for their stable performance. These analyzers not only provide accurate and reliable clinical data for doctors but also offer patients a higher level of medical services. The AC630 hematology analyzer is the latest addition to the hematology analyzer series and its fully automated operation significantly improves the laboratory’s operational efficiency, as well as brings greater convenience to the operator. Lifotronic is also showcasing its complete solution for POCT using fluorescence immunochromatography and colloidal gold rapid detection. The POCT fluorescence immunochromatography analyzer offers several test parameters, is easy to carry, and enables fast detection. Its single-use cartridge design can satisfy the needs of primary healthcare facilities and small to medium-sized labs with low sample volumes.

Related Links:
Lifotronic


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A simple blood sample that allows DNA methylation could identify epigenetic biomarkers (Photo courtesy of 123RF)

Simple Blood Sample Could Identify Epigenetic Biomarkers to Predict CVD Risk in Type 2 Diabetes

People with type 2 diabetes face up to four times higher risk of cardiovascular events such as heart attacks, strokes, and angina compared to individuals without the condition. Yet, current tools used... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The new technology could predict who will benefit from immunotherapy (Photo courtesy of Max Delbrück Center)

New Technology Deciphers Immune Cell Communication to Predict Immunotherapy Response

A healthy immune system depends on complex communication between specialized cell types that detect, alert, and eliminate harmful threats. When these immune signaling pathways break down, the result can... Read more

Microbiology

view channel
Image: MycoMEIA Aspergillus Assay is the first FDA-cleared urine-based test for invasive aspergillosis (Photo courtesy of Pearl Diagnostics)

Urine-Based Assay Diagnoses Common Lung Infection in Immunocompromised People

Invasive Aspergillosis (IA), a life-threatening fungal infection, poses a serious threat to immunocompromised individuals, especially those with hematologic malignancies, transplants, or severe lung diseases.... Read more
MEDLAB 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.